Drug development: 10 PE-backed deals show interest in clinical trials
NMS Capital, QHP Capital, VSS Capital, and FFL Partners are some of the firms persuing opportunities in clinical trials.
16 November 2023•5 mins read
NMS Capital, QHP Capital, VSS Capital, and FFL Partners are some of the firms persuing opportunities in clinical trials.
Phoenix Equity’s Nineteen Group acquires exhibitions organizer Blueprint Event Company
14 hours ago · 1 min read
Platinum Equity seals deal for Chicago propane distributor EDP
15 hours ago · 2 mins read
Industrial Growth Partners inks sale of AdvancedPCB to Amphenol
16 hours ago · 2 mins read
Avance-backed Alchemy Technology Group buys Austin cybersecurity provider Freeit Data Solutions
16 hours ago · 1 min read
A&M Capital buys majority stake in insurance investigations firm Delta Group
16 hours ago · 2 mins read
Hunter Point Capital provides preferred financing to Denver’s Bow River Capital
18 hours ago · 2 mins read
OceanSound-backed Burns Engineering buys district energy engineering firm PRVN Consultants
18 hours ago · 1 min read
